Melanocortin receptors in GtoPdb v.2021.3

Authors

  • Vanni Caruso University of Tasmania
  • Biao-Xin Chai University of Michigan
  • Adrian J. L. Clark St. Bartholomew's Hospital
  • Roger D. Cone University of Michigan
  • Alex N. Eberle Universitsspital
  • Sadaf Farooqi University of Cambridge
  • Tung M. Fong Nevakar, Inc
  • Ira Gantz Merck & Co. Inc.
  • Carrie Haskell-Luevano University of Minnesota
  • Victor J. Hruby University of Arizona
  • Kathleen G. Mountjoy University of Auckland
  • Colin Pouton University of Bath
  • Helgi Schiöth Uppsala University
  • Jeffrey B. Tatro New England Medical Center Hospital
  • Jarl E. S. Wikberg Uppsala University

DOI:

https://doi.org/10.2218/gtopdb/F38/2021.3

Abstract

Melanocortin receptors (provisional nomenclature as recommended by NC-IUPHAR [41]) are activated by members of the melanocortin family (α-MSH, β-MSH and γ-MSH forms; δ form is not found in mammals) and adrenocorticotrophin (ACTH). Endogenous antagonists include agouti and agouti-related protein. ACTH(1-24) was approved by the US FDA as a diagnostic agent for adrenal function test, whilst NDP-MSH was approved by EMA for the treatment of erythropoietic protoporphyria. Several synthetic melanocortin receptor agonists are under clinical development.

Downloads

Published

02-Sep-2021

Issue

Vol. 2021 No. 3 (2021)

Section

Summaries

How to Cite

“Melanocortin receptors in GtoPdb v.2021.3” (2021) IUPHAR/BPS Guide to Pharmacology CITE, 2021(3). doi:10.2218/gtopdb/F38/2021.3.